SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-001132
Filing Date
2023-02-03
Accepted
2023-02-03 13:30:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27679
2 filename2.txt TEXT-EXTRACT 1523
  Complete submission text file 0000000000-23-001132.txt   40273
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filed for) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)